Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS (SHK001)
Sponsor: University of Virginia
Listed as NCT03905603, this EARLY_PHASE1 trial focuses on Polycystic Ovary Syndrome and remains actively recruiting participants. Sponsored by University of Virginia, it has been updated 13 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
Dec 2023 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2023 — Dec 2023 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2022 — Apr 2023 [monthly]
Recruiting EARLY_PHASE1
▶ Show 8 earlier versions
-
May 2021 — Jul 2022 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2021 — May 2021 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2020 — Jan 2021 [monthly]
Recruiting EARLY_PHASE1
-
Nov 2019 — Apr 2020 [monthly]
Recruiting EARLY_PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Aug 2019 — Sep 2019 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
May 2019 — Aug 2019 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Virginia
For direct contact, visit the study record on ClinicalTrials.gov .